Works matching DE "IMMUNE checkpoint inhibitors"

Results: 5000

T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604310

By:

Liu, Yu;
Qin, Denghui;
Fu, Jiejun

Publication type:

Article

Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1595070

By:

Yao, Zhiyuan;
Li, Gengchen;
Pan, Di;
Pei, Zichen;
Fang, Yan;
Liu, Haonan;
Han, Zhengxiang

Publication type:

Article

Bispecific antibody for lung cancer: mechanisms and clinical insights.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1572802

By:

Chen, Wei;
Zhou, Afang;
Zhou, Yunfeng

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Expert consensus on the combination of anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma (2025 edition).

Published in:

China Oncology, 2025, v. 35, n. 5, p. 510, doi. 10.19401/j.cnki.1007-3639.2025.05.010

By:

XUE Liqiong;
XU Tingting;
GUO Ye;
HU Chaosu

Publication type:

Article

Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage IIB-IIIB liver cancer.

Published in:

China Oncology, 2025, v. 35, n. 5, p. 478, doi. 10.19401/j.cnki.1007-3639.2025.05.006

By:

TONG Gang;
HUA Yang;
PENG Wei;
ZHAO Ju;
HU Junwen

Publication type:

Article

Editorial: Immune cell therapy approaches targeting tumor microenvironment.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1628689

By:

Patnaik, Santosh K.;
Kalathil, Suresh Gopi

Publication type:

Article

T cell exhaustion in pediatric B-ALL: current knowledge and future perspectives.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1531145

By:

Atre, Tanmaya;
Reid, Gregor S. D.

Publication type:

Article

Experiences of Cutaneous Immune‐Related Adverse Events: A Qualitative Study in Patients With Cancer Receiving Immune Checkpoint Inhibitors.

Published in:

Dermatologic Therapy, 2025, v. 2025, p. 1, doi. 10.1155/dth/7119579

By:

Yang, Zhihui;
Lu, Ruiqi;
Li, Xingwen;
Liu, Suting;
Luo, Yuanyuan;
Wang, Ziqi;
Zhao, Yang;
Zhang, Lili;
Pimpinelli, Nicola

Publication type:

Article

Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma.

Published in:

International Journal of Cancer, 2025, v. 156, n. 12, p. 2416, doi. 10.1002/ijc.35390

By:

Chivite‐Lacaba, Marta;
Justo, Iago;
Utrero‐Rico, Alberto;
Caso, Oscar;
González‐Cuadrado, Cecilia;
Del Rey, Manuel J.;
Laguna‐Goya, Rocio;
Arroyo‐Ródenas, Javier;
Alfocea‐Molina, Ángel;
Ruigómez‐Martín, Carlota C.;
Serrano, Manuel;
Pascual‐Palacios, Lorena;
Mancebo, María Esther;
Paz‐Artal, Estela

Publication type:

Article

How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis.

Published in:

International Journal of Cancer, 2025, v. 156, n. 12, p. 2352, doi. 10.1002/ijc.35347

By:

Haslam, Alyson;
Olivier, Timothée;
Prasad, Vinay

Publication type:

Article

基于噬菌体展示技术的替雷利珠单抗特异性结合肽筛选鉴定及其应用研究.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 5, p. 513, doi. 10.14009/j.issn.1672-2124.2025.05.001

By:

陈雨;
樊芳;
袁智龙;
张雨欣;
王卓

Publication type:

Article

Predicting 30-Day Cardiotoxicity in Patients Receiving Immune Checkpoint Inhibitors: An Observational Study Utilizing XGBoost.

Published in:

Cardiovascular Toxicology, 2025, v. 25, n. 7, p. 994, doi. 10.1007/s12012-025-09990-6

By:

Li, Jialian;
Chen, Zulu;
Zhu, Yuxi;
Li, Gui;
Li, Yanwei;
Lan, Rui;
Zuo, Zhong

Publication type:

Article

Correction to: Predicting 30-Day Cardiotoxicity in Patients Receiving Immune Checkpoint Inhibitors: An Observational Study Utilizing XGBoost.

Published in:

2025

By:

Li, Jialian;
Chen, Zulu;
Zhu, Yuxi;
Li, Gui;
Li, Yanwei;
Lan, Rui;
Zuo, Zhong

Publication type:

Correction Notice

Novel Composite Scoring System for Predicting Prognosis in Stage IV Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors.

Published in:

Journal of Inflammation Research, 2025, v. 18, p. 6491, doi. 10.2147/JIR.S519724

By:

Yang, Lingbing;
Li, Hongwei;
Xia, Mingyu;
Pu, Xiaomeng

Publication type:

Article

Emerging Immunotherapy Targets in Early Drug Development.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5394, doi. 10.3390/ijms26115394

By:

Morchón-Araujo, Daniel;
Catani, Greta;
Mirallas, Oriol;
Pretelli, Giulia;
Sánchez-Pérez, Vicky;
Vieito, María;
Braña, Irene;
Pujol-Borrell, Ricardo;
Garralda, Elena;
Hernando-Calvo, Alberto

Publication type:

Article

Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5370, doi. 10.3390/ijms26115370

By:

Kado, Soichiro;
Komine, Mayumi

Publication type:

Article

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5068, doi. 10.3390/ijms26115068

By:

Cheng, Kexuan;
Guo, Jiazheng;
Li, Yating;
Kang, Qinglin;
Wang, Rong;
Luo, Longlong;
Wang, Wei;
Lu, Jiansheng

Publication type:

Article

The Combination of CD300c Antibody with PD-1 Blockade Suppresses Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment in Triple-Negative Breast Cancer.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5045, doi. 10.3390/ijms26115045

By:

Kim, Soyoung;
Han, Ik-Hwan;
Lee, Suin;
Park, DaeHwan;
Lee, Hyunju;
Kim, Jongyeob;
Kim, Joon;
Jeon, Jae-Won;
Bae, Hyunsu

Publication type:

Article

Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 4982, doi. 10.3390/ijms26114982

By:

Dal Bo, Michele;
Gambirasi, Marta;
Vruzhaj, Idris;
Cecchin, Erika;
Pishdadian, Abbas;
Toffoli, Giuseppe;
Safa, Amin

Publication type:

Article

Distinct Types of Regulated Cell Death in Melanoma.

Published in:

Cells (2073-4409), 2025, v. 14, n. 11, p. 823, doi. 10.3390/cells14110823

By:

Wu, Qi;
Liang, Shuang;
Shi, Guo-Jun;
Meng, Guo-Liang;
Yang, Sheng-Ju

Publication type:

Article

Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition.

Published in:

Molecules, 2025, v. 30, n. 11, p. 2264, doi. 10.3390/molecules30112264

By:

Liao, Kuo-Shiang;
Zhou, Yixuan;
Chung, Cinya;
Kung, Chih-Chuan;
Ren, Chien-Tai;
Wu, Chung-Yi;
Lou, Yi-Wei;
Chuang, Po-Kai;
Imre, Balázs;
Hsieh, Yves S. Y.;
Wong, Chi-Huey

Publication type:

Article

Adjuvant atezolizumab for early triple-negative breast cancer: The ALEXANDRA/IMpassion030 randomized clinical trial.

Published in:

Breast Cancer Research Review, 2025, n. 47, p. 6

By:

Ignatiadis, M.

Publication type:

Article

Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy.

Published in:

European Journal of Haematology, 2025, v. 114, n. 6, p. 953, doi. 10.1111/ejh.14408

By:

Chung, Clement;
Doan, David

Publication type:

Article

The Utility of Magnetic Resonance Imaging for Hypophysitis Secondary to Immune Checkpoint Inhibitor Use.

Published in:

Clinical Endocrinology, 2025, v. 102, n. 6, p. 699, doi. 10.1111/cen.15240

By:

Qi, Qi Yang Damien;
Vettivel, Jeevan;
Solanki, Krisha;
Davis, Anna;
Russell, Anthony W.;
Bach, Leon A.

Publication type:

Article

Immunotherapy Applications in Urology.

Published in:

Journal of Urological Surgery, 2025, v. 12, n. 2, p. 1, doi. 10.4274/jus.galenos.2025.2024-11-9

By:

Şenoğlu, Yusuf;
Şahin, Bahadır

Publication type:

Article

Case report: ICI-induced hepatitis and myositis with aspergillosis.

Published in:

Oncolog-Hematolog, 2025, n. 71, p. 33

By:

Banciu-Odell, Cornelia;
Castillo, Olivia;
Liang Yu;
Kaur, Avneet;
Singh, Dupinder;
Golestany, Kourosh

Publication type:

Article

Lipidomics reveals biomarkers of the efficacy of first-line ICI therapy combined with chemotherapy in NSCLC.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06542-y

By:

Yu, Jia;
Xu, Hanyan;
Xiong, Fen;
Liu, Xiling;
Lingfei, Meng;
Gao, Hongchang;
Li, Yuping

Publication type:

Article

The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine.

Published in:

Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02378-8

By:

Su, Xiaojun;
Yan, Xiuli;
Zhang, Hui

Publication type:

Article

Malignant mesothelioma with a novel BAP1 germline frameshift mutation treated with dual immune checkpoint inhibitors: A case report.

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15104

By:

Zhou, Na;
Wu, Mingying;
Wang, Chenyu;
Yuan, Mingming;
Cheng, Yuejuan;
Wu, Huanwen;
Gao, Xin;
Yu, Shuangni;
Zhao, Lin

Publication type:

Article

Rechallenge of anti-PD-1 antibody combined with chemotherapy shows promising efficacy in the treatment of advanced metastatic hepatocellular carcinoma: A case report.

Published in:

2025

By:

Tan, Xiang;
Kang, Le;
Chen, Hao;
Liu, Xingyan;
Du, Chi

Publication type:

Case Study

Comprehensive analysis of a palmitoylation-related prognostic signature in colorectal cancer: Implications for immune therapy and personalized treatment.

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15096

By:

Wang, Xiaokang;
Li, Jian;
Wang, Zi;
Wu, Qingyun

Publication type:

Article

Efficacy and safety of BCG and immune checkpoint inhibitors in non-muscle invasive bladder cancer: A meta-analysis with exploratory chemotherapy comparisons.

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15094

By:

Adan, Mohamed Mohamoud;
Mao, Xudong;
Ding, Lifeng;
Abdullahi, Khalid Mohamoud;
Li, Gonghui

Publication type:

Article

Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review).

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15088

By:

Ma, Cheng;
Yu, Xinlin;
Zhang, Xialin;
Su, Lihong;
Jiang, Ou;
Cui, Ran

Publication type:

Article

Sintilimab‑induced acute erosive hemorrhagic gastritis as an adverse reaction of third‑line therapy in a nasopharyngeal carcinoma patient: A case report.

Published in:

2025

By:

Tang, Wenqiang;
Lv, Yun;
Yang, Xiyue;
Gan, Kunyuan;
Feng, Gang;
Li, Jie;
Ni, Lu;
Bai, Yuxi;
Du, Xiaobo;
Gao, Feng

Publication type:

Case Study

Prognostic value of the pretreatment Glasgow prognostic score or modified Glasgow prognostic score in patients with advanced cancer receiving immune checkpoint inhibitors: A systematic review and meta‑analysis.

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15069

By:

Zhang, Lianghui;
Lin, Lili;
Ni, Jie;
Ling, Tao;
Huang, Lingli

Publication type:

Article

Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma.

Published in:

Pharmacotherapy, 2025, v. 45, n. 6, p. 356, doi. 10.1002/phar.70023

By:

Chen, Adrienne H.;
Grana, Allison K.

Publication type:

Article

Severe immunotherapy-related thrombocytopenia in metastatic bone cancer: a multicenter retrospective case series highlighting early recognition and management.

Published in:

2025

By:

Gao, Qian;
Yao, Zhaonong;
Yao, Yuhong;
Liu, Yunxia;
Mao, Jianshui;
Li, Binghao

Publication type:

Case Study

Complete remission in PD-L1 high expression advanced gastric cancer patient with PD-L1 immunotherapy and chemotherapy integration treatment strategy: a case report.

Published in:

2025

By:

Yu, Xiaopeng;
Zhao, Wenwen;
Feng, Qingqing;
Tian, Jin;
Zhao, Lili;
Xiao, Jun;
Wei, Hongmei

Publication type:

Case Study

Neoadjuvant radiotherapy combined with targeted and immune therapies achieves a pathological complete response in borderline resectable gallbladder cancer: a case report and literature review.

Published in:

2025

By:

Li, Tao;
Li, Zhiqin;
Li, Keren;
Li, Gong;
Li, Guangxin;
Zhao, Ying

Publication type:

Case Study

Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1564865

By:

Zhang, Xi;
Lu, Hongzhi;
Lv, Yuanshi;
Gao, Hong;
Jin, Hui

Publication type:

Article

Commentary: Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1543608

By:

Xia, Jie-Qiang;
Fan, Jian;
Shi, Guang-Qing;
Sun, Hao

Publication type:

Article

Harnessing delta-like ligand 3: bridging biomarker discovery to next-generation immunotherapies in refractory small cell lung cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1592291

By:

Ji, Kangkang;
Guo, Lin;
Zuo, Dianbao;
Feng, Mingqian;
Chen, Xin;
Zhao, Zhenggang;
Tang, Jing;
Chen, Guoping

Publication type:

Article

Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2/HO-1/GPX4 axis.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1558814

By:

Luo, Jing;
Zhi, Qiongjie;
Li, Dongxia;
Xu, Yue;
Zhu, Hui;
Zhao, Lujun;
Ren, Guibing;
Wang, Jian;
Liu, Ningbo

Publication type:

Article

CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1538652

By:

Wang, Wenjing;
Liu, Dan;
Wang, Lilin;
Aishan, Maimaitijiang Wubuli;
Chen, Li;
Zheng, Sujun;
Lu, Junfeng

Publication type:

Article

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1605958

By:

Wu, Yutong;
Zhou, Yue;
Xia, Shiyue;
Meng, Zhaoyou

Publication type:

Article

Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1596842

By:

Li, Chen;
Ding, Yi;
Cai, Shanshan;
Liu, Bai Cheng;
Wang, Xiufeng

Publication type:

Article

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1592761

By:

Wang, Zhe;
Huang, Danxue;
Li, Su;
Ke, Liyuan

Publication type:

Article

Dendritic cell-based immunotherapy for head and neck squamous cell carcinoma: advances and challenges.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1573635

By:

Chen, Wenyue;
Li, Zhengqiang;
Tang, Jin;
Liu, Shuguang

Publication type:

Article

A comprehensive review of using nanomaterials in cancer immunotherapy: Pros and Cons of clinical usage.

Published in:

3 Biotech, 2025, v. 15, n. 7, p. 1, doi. 10.1007/s13205-025-04362-x

By:

Rashid, Hebah;
Acharya, Swati;
Muhammad, Huzaifa;
Aziz, Mohammad Azhar

Publication type:

Article